Medicare Approves Game-Changing Device
for Apnea and Snoring
Chairside-fabricated device costs hundred less and has Lifetime Warranty
September 25, 2019 St. Pete Beach, FLAs the millions-strong baby-boomer generation continues to increase the utilization of Medicare, so has the growth and demand for treatment of obstructive sleep apnea and snoring.
But there is a problem. While Medicare reimbursements for laboratory diagnostics and c-pap devices keep up with the demand, for those patients who cannot tolerate c-pap and require a mandibular advancement device (MAD) supplied by a dentist, the system comes to a screeching halt.
The provision of an FDA and Medicare cleared MAD requires multiple dental visits, a hefty laboratory fee to fabricate the device, and potential re-fittings and adjustments, with the hope that the patient can tolerate the device. Therefore, in order to cover the costs, the dental practice must charge thousands of dollars, while Medicare reimburses only a small percentage of that. Unfortunately, countless Medicare patients and those without private insurance simply cannot afford the treatment that can dramatically improve, or save, their lives.
The new SnoreHook Splint, developed and patented by James Boyd, DDS, a dentist who suffered from obstructive sleep apnea himself, has been cleared by the FDA and approved for Medicare reimbursement, and solves these problems. The SnoreHook Splint is fabricated in the dental office, taking 20 minutes, eliminating the hundreds of dollars in laboratory fees and multiple office visits. It is readily and easily adjusted or repaired. All of the parts and components have a lifetime warranty. The cost to the dentist? $78.
The SnoreHook Splint (www.SnoreHook.com) allows the dentist to provide a high-quality and durable treatment for obstructive sleep apnea, regardless of the patient’s insurance coverage, at a reasonable cost for all. The company offers a free sample to interested dentists and volume discount pricing.